CORPORATE NEWS

Biohacks GmbH issues corporate bonds

• Strongly growing supplier of high-quality functional food products issues bonds to finance growth
• Private placement of a corporate bond with a coupon of 5.0% p.a. and a maturity of 2 years
• Public offering of a further bond with a coupon of 3.5% p.a. and a maturity of 1 year planned
• Investors to benefit from the megatrend "biohacking" in the food sector

Dusseldorf, 14 December 2020. Biohacks GmbH ("Biohacks", "the Company"), a provider of high-quality functional food products, is issuing a corporate bond (ISIN: DE000A3H20J8) with a volume of up to € 8,000,000 in a private placement. The security has an interest rate of 5.0% p.a. with a maturity of 2 years. With a minimum subscription of 100,000 Euro, the bond is targeted at qualified investors. The proceeds of the issue will be used to finance growth, in particular international expansion, the development of new products and the intensification of product marketing.

In addition, the company plans to issue a further bond (ISIN DE000A3H20H2) with a volume of up to € 999,000, which is aimed at private investors. It has an interest rate of 3.5% p.a. with a maturity of 1 year and will be issued in a public offering with a denomination of 1,000 Euro. The offer is, inter alia, subject to the condition of the publication of a securities information sheet, which is expected to be authorised by the Federal Financial Supervisory Authority on 21 December 2020. The legally relevant securities information sheet (WIB) and the bond terms and conditions are expected to be available for download from from 21 December 2020.

Torsten Schwehm, Managing Director of Biohacks GmbH:
"Biohacking is a megatrend in the field of nutrition. With the Biohacks bond investors are participating in a strongly growing company in a dynamic future market. With performance-enhancing products made from natural ingredients and a consistent expansion strategy we will be able to considerably increase our market share. The placement of the corporate bonds puts us in a position to accelerate the pace of growth. In the medium term, we are aiming for annual sales of about 90 million euros with an attractive margin."

Biohacks develops and distributes high quality vegan and organic certified food products that help people achieve their optimal performance. The functional food products "Hang & Over" and "Sleep & Well" are already marketed through more than 4,000 branches of renowned retailers such as DM, Edeka and REWE as well as through Amazon. As part of its growth strategy, Biohacks plans to expand its product range and will soon launch a new vegan energy drink alternative with natural ingredients on the market. In Germany alone the market volume of energy drinks is over 1.2 billion euros. Biohacks benefits from the trend towards natural and vegan products.

Key data corporate bond 2020/2022
Issue: Biohacks GmbH
Issue volume: 8,000,000 EUR
WKN / ISIN: ISIN: DE000A3H20J8; WKN: A3H20J
Coupon: 5.0 % p. a.
Term: 2 years, from 22 December 2020
Denomination / issue price: 100,000 EUR / 100 %
Repayment: Due on 21 December 2022 at nominal value (100 %)
Type of security: Bearer bond
Issue/value date: 22 December 2020

Key data corporate bond 2020/2021
Issue: Biohacks GmbH
Issue volume: 999,000 EUR
WKN / ISIN: WKN: DE000A3H20H2; WKN: A3H20H
Coupon: 3.5 % p. a.
Term: 1 year, from 22 December 2020
Denomination / issue price: 1,000 EUR / 100 %
Repayment: Due on 21 December 2021 at nominal value (100 %)
Type of security: Bearer bond
Issue/value date: 22 December 2020

Further information on the bonds can be found here: .

Corporate contact
Biohacks GmbH
Dr. Ingo Lange - Managing Director
Rather Str. 25
40476 Düsseldorf
0 24

Business and financial press
Kirchhoff Consult AG
Jan Hutterer
Borselstraße 20
22765 Hamburg
T 0


About Biohacks GmbH
Biohacks GmbH develops and distributes high quality vegan and organic certified products that help people to achieve their optimal performance. The functional food products "Hang & Over" and "Sleep & Well" are sold via online platforms and more than 4,000 branches of renowned retailers. The company is pursuing a consistent expansion strategy with the introduction of further products and entry into new markets. In the medium term, the company is aiming for annual sales of about 90 million euros with an attractive margin.

Further information is available at: .

IMPORTANT NOTICE
This publication is neither an offer to sell nor a solicitation of an offer to buy any securities. This publication is for informational purposes only and is not, and should not be construed as, an offer or invitation to sell or issue, or the solicitation of an offer to buy or subscribe for, any securities. With respect to the bearer bonds with ISIN: DE000A3H20J8, there was and is no public offering. A prospectus will not be prepared in connection with any offering of the bearer bonds. The bearer bonds may not be offered to the public in jurisdictions under circumstances in which the issuer of the bearer bonds is required to prepare or register a prospectus or offering document for the bearer bonds in such jurisdiction.

The purchase or subscription of the bearer bonds of Biohacks GmbH with ISIN: DE000A3H20H2 can therefore only be made on the basis of the securities information sheet permitted by the German Federal Financial Supervisory Authority ("BaFin"), which can be downloaded free of charge from this website after the permission. Insofar as forecasts, expectations, opinions or assessments are expressed on this and the following pages or forward-looking statements are made outside the Securities Information Sheet, it should be noted that only the information in the Securities Information Sheet is authoritative for assessing the bearer bonds.

Before making any investment decision, it is advised to consult the Securities Information Sheet for the Bearer Bonds of Biohacks GmbH with ISIN: DE000A3H20H2, including any updates, and otherwise, i.e. also with regard to the Bearer Bonds of Biohacks GmbH with ISIN: DE000A3H20J8, other generally accessible sources of information on the Bearer Bonds, and to obtain professional advice, taking into account the respective personal financial and investment situation.

The distribution of this publicatin and the offer and sale of the bearer bonds in certain jurisdictions may be restricted by law. Persons reading this communication should inform themselves about and observe any such restrictions.

This publication does not constitute an offer to sell or the solicitation of an offer to buy any securities in the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under the laws of any state of the United States, and may not be offered or sold in the United States absent registration or a valid exemption from registration or in a transaction not subject to the registration requirements of the Securities Act. The bearer bonds are not being offered in the United States. This publication and the information contained herein may not be distributed or transmitted in the United States or in any other jurisdiction in which the offer or sale of the securities referred to herein is prohibited by applicable law and should not be transmitted to publications of general circulation in the United States. The bearer bonds are being offered and sold exclusively outside the United States in reliance on Regulation S under the Securities Act.

To the extent that the offering referred to in this publication is made in member states of the European Economic Area ("EEA") where Regulation (EU) 2017/1129 ("Prospectus Regulation"), as amended, applies (each a "Relevant Member State"), this publication and any offer made pursuant to it is directed only at persons who are 'qualified investors' within the meaning of Article 2 lit. e of the Prospectus Regulation ("Qualified Investors"). Any person in the relevant Member States who acquires securities or to whom securities are offered in an offering (an 'Investor') will be deemed to have represented and agreed to be a Qualified Investor.